SQ.line KERRISON— 510(k) K223596

Substantially Equivalent

Aesculap, Inc.

FDA 510(k) clearance K223596 for SQ.line KERRISON, Substantially Equivalent on 2023-06-29. Applicant: Aesculap, Inc..

Clearance details

Applicant: Aesculap, Inc.
Product code: Code HAE
Advisory panel: Neurology
Date received: 2022-12-02
Decision date: 2023-06-29
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Center Valley, PA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.